This study aims to analyze the efficacy and safety of wearable electrocardiogram (ECG) monitoring by simultaneously attaching a single-channel patch-type wearable ECG monitoring device (HiCardi+ by Mezoo Co., Ltd.) and a telemetry device (IntelliVue MX40 by Philips) used in actual wards to patients prescribed with ECG monitoring
Adults aged 19 years or older
Patients admitted to Chonnam National University Hospital who require ECG monitoring
Individuals who have expressed their intention to participate in this study or have obtained written consent from a proxy
Individuals who are unable to provide consent themselves or through a legally designated representative
Individuals deemed unsuitable for participation in the clinical trial based on the researcher's judgment
Mezoo Co., Ltd.
Lead sponsor